Calton & Associates’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-23,781
| Closed | -$117K | – | 191 |
|
|
2023
Q4 | $117K | Buy |
+23,781
| New | +$117K | 0.05% | 234 |
|
|
2023
Q3 | – | Sell |
-14,020
| Closed | -$94.1K | – | 103 |
|
|
2023
Q2 | $94.1K | Sell |
14,020
-533
| -4% | -$3.58K | 0.04% | 206 |
|
|
2023
Q1 | $129K | Buy |
14,553
+268
| +2% | +$2.37K | 0.06% | 221 |
|
|
2022
Q4 | $109K | Buy |
14,285
+3,863
| +37% | +$29.5K | 0.04% | 270 |
|
|
2022
Q3 | $74K | Sell |
10,422
-271
| -3% | -$1.92K | 0.04% | 205 |
|
|
2022
Q2 | $86K | Sell |
10,693
-662
| -6% | -$5.32K | 0.05% | 229 |
|
|
2022
Q1 | $157K | Buy |
+11,355
| New | +$157K | 0.05% | 336 |
|
|
2021
Q1 | – | Sell |
-3,734
| Closed | -$221K | – | 398 |
|
|
2020
Q4 | $221K | Buy |
+3,734
| New | +$221K | 0.04% | 344 |
|